Annual Gross Profit
$212.61 M
-$483.70 M-69.47%
31 December 2023
Summary:
Novavax annual gross profit is currently $212.61 million, with the most recent change of -$483.70 million (-69.47%) on 31 December 2023. During the last 3 years, it has risen by +$15.03 million (+7.61%). NVAX annual gross profit is now -69.47% below its all-time high of $696.31 million, reached on 31 December 2022.NVAX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$23.89 M
-$345.35 M-93.53%
30 September 2024
Summary:
Novavax quarterly gross profit is currently $23.89 million, with the most recent change of -$345.35 million (-93.53%) on 30 September 2024. Over the past year, it has dropped by -$74.53 million (-75.72%). NVAX quarterly gross profit is now -95.95% below its all-time high of $589.47 million, reached on 31 March 2022.NVAX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$526.20 M
+$100.76 M+23.68%
30 September 2024
Summary:
Novavax TTM gross profit is currently $526.20 million, with the most recent change of +$100.76 million (+23.68%) on 30 September 2024. Over the past year, it has increased by +$176.51 million (+50.48%). NVAX TTM gross profit is now -43.06% below its all-time high of $924.09 million, reached on 30 September 2021.NVAX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -75.7% | +50.5% |
3 y3 years | +7.6% | +103.3% | +166.3% |
5 y5 years | - | - | - |
NVAX Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -69.5% | +7.6% | -96.0% | +103.3% | -34.6% | +1313.8% |
5 y | 5 years | -69.5% | +849.7% | -96.0% | +103.3% | -43.1% | +1313.8% |
alltime | all time | -69.5% | >+9999.0% | -96.0% | +103.3% | -43.1% | +1313.8% |
Novavax Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $23.89 M(-93.5%) | $526.20 M(+23.7%) |
June 2024 | - | $369.24 M(+965.8%) | $425.45 M(+0.1%) |
Mar 2024 | - | $34.65 M(-64.8%) | $424.85 M(+21.5%) |
Dec 2023 | $212.61 M(-69.5%) | $98.42 M(-228.0%) | $349.69 M(-2.1%) |
Sept 2023 | - | -$76.86 M(-120.9%) | $357.33 M(-43.1%) |
June 2023 | - | $368.65 M(-1009.9%) | $627.91 M(+260.6%) |
Mar 2023 | - | -$40.51 M(-138.2%) | $174.11 M(-78.3%) |
Dec 2022 | $696.31 M(+252.4%) | $106.06 M(-45.2%) | $804.09 M(-2922.9%) |
Sept 2022 | - | $193.71 M(-327.5%) | -$28.48 M(-34.3%) |
June 2022 | - | -$85.15 M(-114.4%) | -$43.35 M(-112.8%) |
Mar 2022 | - | $589.47 M(-181.1%) | $339.82 M(+72.0%) |
Dec 2021 | $197.58 M(+782.5%) | -$726.51 M(-506.2%) | $197.58 M(-78.6%) |
Sept 2021 | - | $178.84 M(-40.0%) | $924.09 M(+24.0%) |
June 2021 | - | $298.02 M(-33.4%) | $745.25 M(+66.6%) |
Mar 2021 | - | $447.23 M(>+9900.0%) | $447.23 M(+3694.9%) |
Dec 2020 | $22.39 M(+203.2%) | - | - |
Sept 2014 | - | $4.19 M(+32.6%) | $11.79 M(+16.4%) |
June 2014 | - | $3.16 M(-28.9%) | $10.12 M(+14.2%) |
Mar 2014 | - | $4.44 M(+75.8%) | $8.87 M(-3.2%) |
Sept 2013 | - | $2.53 M(+33.0%) | $9.16 M(+7.0%) |
June 2013 | - | $1.90 M(-10.5%) | $8.56 M(-1.0%) |
Mar 2013 | - | $2.12 M(-18.9%) | $8.65 M(+17.1%) |
Dec 2012 | $7.38 M(-3.9%) | $2.61 M(+35.7%) | $7.38 M(+0.1%) |
Sept 2012 | - | $1.93 M(-2.9%) | $7.37 M(-10.8%) |
June 2012 | - | $1.99 M(+131.9%) | $8.26 M(+2.7%) |
Mar 2012 | - | $856.00 K(-67.1%) | $8.05 M(+4.8%) |
Dec 2011 | $7.68 M(+2140.5%) | $2.60 M(-7.6%) | $7.68 M(+49.8%) |
Sept 2011 | - | $2.82 M(+59.2%) | $5.13 M(+106.3%) |
June 2011 | - | $1.77 M(+260.5%) | $2.49 M(+243.5%) |
Mar 2011 | - | $491.00 K(+862.7%) | $724.00 K(+111.1%) |
Dec 2010 | $343.00 K(+5.5%) | $51.00 K(-70.9%) | $343.00 K(-6.3%) |
Sept 2010 | - | $175.00 K(+2400.0%) | $366.00 K(-6.6%) |
June 2010 | - | $7000.00(-93.6%) | $392.00 K(-5.3%) |
Mar 2010 | - | $110.00 K(+48.6%) | $414.00 K(+27.4%) |
Dec 2009 | $325.00 K(-69.5%) | $74.00 K(-63.2%) | $325.00 K(+1.2%) |
Sept 2009 | - | $201.00 K(+593.1%) | $321.00 K(+2.2%) |
June 2009 | - | $29.00 K(+38.1%) | $314.00 K(+10.2%) |
Mar 2009 | - | $21.00 K(-70.0%) | $285.00 K(-60.5%) |
Dec 2008 | $1.06 M(-17.6%) | $70.00 K(-63.9%) | $722.00 K(-76.5%) |
Sept 2008 | - | $194.00 K(-57.6%) | $3.07 M(+28.0%) |
Mar 2008 | - | $458.00 K(-81.1%) | $2.40 M(+2.0%) |
Dec 2007 | $1.29 M | $2.42 M(+1004.6%) | $2.35 M(+41.4%) |
Sept 2007 | - | $219.00 K(-131.4%) | $1.66 M(+13.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2007 | - | -$697.00 K(-269.6%) | $1.47 M(-20.4%) |
Mar 2007 | - | $411.00 K(-76.2%) | $1.84 M(+55.3%) |
Dec 2006 | $1.50 M(-69.6%) | $1.73 M(+7421.7%) | $1.19 M(-72.5%) |
Sept 2006 | - | $23.00 K(-107.1%) | $4.32 M(-15.2%) |
June 2006 | - | -$322.00 K(+31.4%) | $5.09 M(-10.7%) |
Mar 2006 | - | -$245.00 K(-105.0%) | $5.71 M(+15.6%) |
Dec 2005 | $4.93 M(+3.4%) | $4.86 M(+508.6%) | $4.93 M(+554.2%) |
Sept 2005 | - | $799.00 K(+177.4%) | $754.00 K(+209.0%) |
June 2005 | - | $288.00 K(-128.3%) | $244.00 K(-83.3%) |
Mar 2005 | - | -$1.02 M(-248.7%) | $1.46 M(-73.1%) |
Dec 2004 | $4.77 M(-51.0%) | $684.00 K(+136.7%) | $5.43 M(-33.1%) |
Sept 2004 | - | $289.00 K(-80.8%) | $8.13 M(-28.4%) |
June 2004 | - | $1.50 M(-49.1%) | $11.34 M(-3.3%) |
Mar 2004 | - | $2.96 M(-12.4%) | $11.73 M(+20.5%) |
Dec 2003 | $9.73 M(-15.0%) | $3.38 M(-3.8%) | $9.73 M(+19.8%) |
Sept 2003 | - | $3.51 M(+85.9%) | $8.12 M(+31.4%) |
June 2003 | - | $1.89 M(+96.6%) | $6.18 M(-20.2%) |
Mar 2003 | - | $960.00 K(-45.7%) | $7.75 M(-32.3%) |
Dec 2002 | $11.45 M(-42.8%) | $1.77 M(+12.9%) | $11.45 M(-22.0%) |
Sept 2002 | - | $1.57 M(-54.7%) | $14.67 M(-15.3%) |
June 2002 | - | $3.46 M(-25.8%) | $17.32 M(-16.5%) |
Mar 2002 | - | $4.66 M(-6.7%) | $20.75 M(+3.7%) |
Dec 2001 | $20.01 M(+552.1%) | $4.99 M(+18.4%) | $20.01 M(+24.2%) |
Sept 2001 | - | $4.22 M(-38.8%) | $16.11 M(+30.3%) |
June 2001 | - | $6.88 M(+75.5%) | $12.37 M(+100.2%) |
Mar 2001 | - | $3.92 M(+259.2%) | $6.18 M(+101.4%) |
Dec 2000 | $3.07 M(+91.8%) | $1.09 M(+130.9%) | $3.07 M(+10.5%) |
Sept 2000 | - | $473.00 K(-31.6%) | $2.78 M(+6.6%) |
June 2000 | - | $692.00 K(-14.8%) | $2.60 M(+36.2%) |
Mar 2000 | - | $812.00 K(+1.5%) | $1.91 M(+47.1%) |
Dec 1999 | $1.60 M(+60.0%) | $800.00 K(+166.7%) | $1.30 M(+62.5%) |
Sept 1999 | - | $300.00 K(+50.0%) | $800.00 K(+14.3%) |
Mar 1999 | - | $200.00 K(-33.3%) | $700.00 K(-12.5%) |
Dec 1998 | $1.00 M(+25.0%) | $300.00 K(+50.0%) | $800.00 K(-27.3%) |
June 1998 | - | $200.00 K(-33.3%) | $1.10 M(+22.2%) |
Mar 1998 | - | $300.00 K(-25.0%) | $900.00 K(+12.5%) |
Dec 1997 | $800.00 K(+100.0%) | $400.00 K(+100.0%) | $800.00 K(+60.0%) |
Sept 1997 | - | $200.00 K(0.0%) | $500.00 K(-28.6%) |
Mar 1997 | - | $200.00 K(+100.0%) | $700.00 K(0.0%) |
Dec 1996 | $400.00 K | $100.00 K(-50.0%) | $700.00 K(+16.7%) |
Sept 1996 | - | $200.00 K(0.0%) | $600.00 K(+50.0%) |
June 1996 | - | $200.00 K(0.0%) | $400.00 K(+100.0%) |
Mar 1996 | - | $200.00 K | $200.00 K |
FAQ
- What is Novavax annual gross profit?
- What is the all time high annual gross profit for Novavax?
- What is Novavax quarterly gross profit?
- What is the all time high quarterly gross profit for Novavax?
- What is Novavax quarterly gross profit year-on-year change?
- What is Novavax TTM gross profit?
- What is the all time high TTM gross profit for Novavax?
- What is Novavax TTM gross profit year-on-year change?
What is Novavax annual gross profit?
The current annual gross profit of NVAX is $212.61 M
What is the all time high annual gross profit for Novavax?
Novavax all-time high annual gross profit is $696.31 M
What is Novavax quarterly gross profit?
The current quarterly gross profit of NVAX is $23.89 M
What is the all time high quarterly gross profit for Novavax?
Novavax all-time high quarterly gross profit is $589.47 M
What is Novavax quarterly gross profit year-on-year change?
Over the past year, NVAX quarterly gross profit has changed by -$74.53 M (-75.72%)
What is Novavax TTM gross profit?
The current TTM gross profit of NVAX is $526.20 M
What is the all time high TTM gross profit for Novavax?
Novavax all-time high TTM gross profit is $924.09 M
What is Novavax TTM gross profit year-on-year change?
Over the past year, NVAX TTM gross profit has changed by +$176.51 M (+50.48%)